SCHEMBL25850585

SCHEMBL25850585

c1ccc(-c2ccc(N(c3cccc(-c4ccccc4)c3)c3ccc4c(c3)sc3cccc(-c5ccc(-c6nc(-c7ccccc7)cc(-c7ccccc7)n6)cc5)c34)cc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 8/20 0.36
KMT2A Q03164 8/20 0.36
ALDH1A1 P00352 6/20 0.36
MAPT P10636 6/20 0.36
HPGD P15428 6/20 0.36
NTSR1 P30989 1/20 0.36
KDM4E B2RXH2 4/20 0.35
LMNA P02545 2/20 0.35
GLA P06280 1/20 0.35
LIMK1 P53667 2/20 0.34
ADK P55263 1/20 0.33
MAOB P27338 5/20 0.33
MAOA P21397 3/20 0.33
ADORA2A P29274 1/20 0.32
ADORA1 P30542 1/20 0.32
NPSR1 Q6W5P4 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31
F9 P00740 1/20 0.31
CYP2C19 P33261 1/20 0.31
AURKA O14965 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25853441 0.94 LIMK1 (0.33) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL26420615 0.92 LIMK1 (0.37) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL26420632 0.92 MEN1 (0.38) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL26420940 0.92 MEN1 (0.37) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL26420617 0.90 MEN1 (0.36) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL26420495 0.90 LIMK1 (0.33) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL25854590 0.89 ADK (0.32) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL25849400 0.89 LIMK1 (0.32) LIMK1ADORA2AADORA1F9
SCHEMBL26420515 0.88 LIMK1 (0.32) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL26420480 0.88 LIMK1 (0.32) MEN1KMT2AALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230320211-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-10-05 US disclosed
US-20230320211-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-10-05 US disclosed
EP-4206198-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT Materials Co., Ltd. (KR) 2023-07-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320211-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE ORC3, CRY1, SUN2 MEN1 1044/4885KMT2A 1149/4885ALDH1A1 544/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.